Results 121 to 130 of about 119,784 (210)

High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism. [PDF]

J Thromb Haemost, 2023
Grover SP, Snir O, Hindberg K, Englebert TM, Braekkan SK, Morelli VM, Jensen SB, Wolberg AS, Mollnes TE, Ueland T, Mackman N, Hansen JB.   +11 more
europepmc   +1 more source

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. [PDF]

Front Immunol, 2023
Urwyler P, Leimbacher M, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, Stüssi-Helbling M, Albrich WC, Sendi P, Osthoff M.   +14 more
europepmc   +1 more source

C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle-aged patients. [PDF]

Clin Transl Allergy
Atay Sensoy GG, Baykız D, Toprak İD, Eyice Karabacak D, Bektas E, Unal D, Gelincik A, Demir S.   +7 more
europepmc   +1 more source

Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor. [PDF]

Front Med (Lausanne), 2022
Triggianese P, Senter R, Petraroli A, Zoli A, Lo Pizzo M, Bignardi D, Di Agosta E, Agolini S, Arcoleo F, Rossi O, Modica S, Greco E, Chimenti MS, Spadaro G, De Carolis C, Cancian M.   +15 more
europepmc   +1 more source

Recurrent Intestinal Angioedema with Normal C1-Inhibitor: A Case Report. [PDF]

Medicina (Kaunas)
Jevtic D, Taylor A, Dumic I, Sviggum E, Nordstrom CW, Antic M.   +5 more
europepmc   +1 more source

Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing. [PDF]

J Allergy Clin Immunol Glob, 2023
Adatia A, Ritchie B.
europepmc   +1 more source

Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor. [PDF]

J Allergy Clin Immunol Glob
Magerl M, Riedl MA, Arruda LK, Bauer A, Berardi A, Bernstein JA, Bouillet L, Buckland M, Buttgereit T, Cohn DM, Craig T, Criado RF, Du-Thanh A, Fain O, Gonçalo M, Greve J, Grumach AS, Guilarte M, Katelaris C, Kinaciyan T, Latysheva EA, Lleonart R, Llosa OC, Mansour E, Grivcheva-Panovska V, Parisi C, Rosario Filho NA, Santos AS, Staubach P, Valerieva A, Rodrigues Valle SO, Danese S, Ulloa J, Audhya PK, Maurer M.   +34 more
europepmc   +1 more source

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency. [PDF]

Int J Mol Sci, 2022
Dyga W, Obtulowicz A, Mikolajczyk T, Bogdali A, Dubiela P, Obtulowicz K.   +5 more
europepmc   +1 more source

One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency. [PDF]

Front Allergy
Bara NA, Nădășan V, Deleanu D.
europepmc   +1 more source

Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor. [PDF]

Front Allergy, 2022
Gabriel N, Marcelino F, Ferriani MPL, Arruda LK, Campos RA, Gonçalves RF, Chong-Neto H, Rosario Filho N, Valle SOR, Pesquero JB, Grumach AS.   +10 more
europepmc   +1 more source